
Corporate Partners
Our Corporate Partners share our values and support us in bringing evidence-based, clinically-relevant innovations to the dental profession.
Founded in June 2015, Amend Surgical is focused on the development and commercialization of novel materials for the oral surgical and dental market. In 2020, Amend Surgical licensed the exclusive rights for a novel, tough, surgical adhesive for dental and oral surgical applications from the Wyss Institute at Harvard University. Amend Tissue Tape™ is a wound and barrier technology that forms long lasting ionic and covalent bonds that tightly interconnect the tough adhesive to biologic tissue, even in challenging wet environments like the oral cavity. A clinical assessment over extraction sockets will begin in summer-2025 and FDA clearance as a non-resorbable wound dressing is expected late-2025.
Substantial work has also been completed on a resorbable version of the product line. Amend is initially pursuing the resorbable technology as a suture-less connector and wrap option for peripheral nerve repair procedures. The brand name for our resorbable product is Tissure™. For more information, please visit amendsurgical.com.
Amend Tissue Tape™
